Other OTC - Delayed Quote USD

BioAdaptives, Inc. (BDPT)

0.0004 -0.0001 (-10.00%)
At close: April 25 at 3:57 PM EDT
Loading Chart for BDPT
DELL
  • Previous Close 0.0005
  • Open 0.0005
  • Bid --
  • Ask --
  • Day's Range 0.0004 - 0.0005
  • 52 Week Range 0.0003 - 0.0060
  • Volume 28,131,258
  • Avg. Volume 36,582,752
  • Market Cap (intraday) 486,080
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioAdaptives, Inc. investigates, markets, and distributes natural plant and algal-based products for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, enhances wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow. It also provides animal products, including Canine All-in-One and Equine All-in-One products for dogs and horses. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

www.shopbioadaptives.com

3

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BDPT

Performance Overview: BDPT

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BDPT
10.00%
S&P 500
5.84%

1-Year Return

BDPT
40.00%
S&P 500
22.03%

3-Year Return

BDPT
98.50%
S&P 500
20.77%

5-Year Return

BDPT
99.64%
S&P 500
72.46%

Compare To: BDPT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BDPT

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    437.47k

  • Enterprise Value

    706.38k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.81

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    24.73

  • Enterprise Value/EBITDA

    -1.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -202.50%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    28.57k

  • Net Income Avi to Common (ttm)

    -712.47k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    60.78k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    208.62k

Company Insights: BDPT

People Also Watch